Avania names Marie Engels chief financial officer

Avania appointed Marie Engels, CIMA, as chief financial officer as the MedTech-focused CRO expands its global services. Engels brings more than 20 years of finance leadership experience across major CROs and will lead Avania’s global finance organization.

Why it matters: - Avania is adding a finance leader with deep CRO experience as the company expands its MedTech-focused services worldwide. - The hire supports Avania’s effort to scale across borders while maintaining financial discipline during growth.

What happened: - Avania named Marie Engels, CIMA, as chief financial officer. - Engels joined Avania’s executive leadership team to lead the company’s global finance organization. - The announcement was made Sept. 29, 2026, in Marlborough, Massachusetts.

The details: - Engels brings more than two decades of global finance leadership experience in the CRO industry. - Her background includes leadership roles at Kapadi, Syneos Health, IQVIA and ICON. - Her career has focused on helping organizations scale, integrate acquisitions and build finance operations. - Engels is a Chartered Global Management Accountant. - She holds degrees in economics, management and business administration from the Catholic University of Lille in France. - Jason Monteleone, president and CEO of Avania, said Engels has spent her career building the systems and teams that help global CROs grow across borders. - Monteleone said Engels’ experience supporting high-growth organizations will be valuable as Avania builds on its momentum. - Engels said she was drawn to Avania’s reputation as a trusted partner to MedTech innovators, the strength of its team and its future vision.

Between the lines: - Avania is signaling that finance leadership is part of its next growth phase, not just an administrative hire. - The company is positioning itself around the MedTech sector, where clinical, regulatory and market access needs differ from broader life sciences work. - Engels’ background suggests Avania wants a CFO comfortable with both scaling and integration as the company grows.

What's next: - Engels will oversee Avania’s global finance operations as the company continues expanding its MedTech services. - Avania is likely to lean on finance leadership to support growth, acquisitions and international operations. - The company says it has executed more than 1,250 clinical trials and more than 500 regulatory and market access filings. - Avania says it supports both leading MedTech companies and emerging innovators.

The bottom line: - Avania is betting that a CFO with deep CRO and global finance experience will help sustain growth in a specialized and competitive MedTech market. - More information is available at Avania’s website. - The company’s LinkedIn page is here.